Abstract: The present invention is directed to a polypropylene composition (C) a melt flow rate MFR2 (230° C.) determined according to ISO 1133 in the range of 15 to 40 g/10 min, the use of said polypropylene composition (C) for the production of a foamed article and a foamed article comprising said polypropylene composition (C).

Abstract: The present invention relates to a process for the preparation of methacrylic acid or methacrylic esters, comprising the process steps of IA) preparation of 3-hydroxyisobutyric acid by a process comprising the process step of bringing a cell which has been genetically modified in comparison with its wild type in such a way that it is capable of forming more 3-hydroxyisobutyric acid, or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid in comparison with its wild type, into contact with a nutrient medium comprising, as carbon source, carbohydrates, glycerol, carbon dioxide, methanol, L-valine or L-glutamate under conditions under which 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid are formed from the carbon source, if appropriate, isolation of the 3-hydroxyisobutyric acid from the nutrient medium and also, if appropriate, neutralization of the 3-hydroxyisobutyric acid, IB) dehydration of the 3-hydroxyisobutyric acid with formation of methacrylic acid and also, where

Abstract: A computer cluster includes: a first compartment, further including a plurality of first physical nodes configured to provide first resources for a first infrastructural virtual instance and second resources for guest virtual instances; and a second compartment, further including a plurality of second physical nodes configured to provide third resources for a second infrastructural virtual instance and fourth resources for guest virtual instances. Each of the plurality of physical nodes further includes a mass storage device, the mass storage device further including: a partition provided for booting the physical node; a partition as part of resources assigned to an infrastructural virtual instance; and a partition as part of other resources. The first infrastructural virtual instance and the second infrastructural virtual instance are configured for monitoring each other.

Abstract: The present invention relates to a cell which has been modified in comparison with its wild type in such a way that it is capable of forming more, by comparison with its wild, 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid via methylmalonate-semialdehyde or 3-hydroxybutyryl-coenzyme A as precursors. The invention also relates to a method of generating a genetically modified cell, to the genetically modified cell obtainable by these methods, to a method of producing 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid, to a method of producing methacrylic acid or methacrylic esters, and to a method of producing polymethacrylic acid or polymethacrylic esters. The present invention furthermore relates to an isolated DNA, to a vector, to the use of this vector for transforming a cell, to a transformed cell, and to a polypeptide.

Abstract: A computer cluster includes: a first compartment, further including a plurality of first physical nodes configured to provide first resources for guest virtual instances, each of the plurality of first physical nodes further including a mass storage device, the mass storage device further including: a first partition provided for booting the first physical node; and a second partition as part of the first resources; and a second compartment, further including a plurality of second physical nodes configured to provide second resources for guest virtual instances, each of the plurality of second physical nodes further including a mass storage device, the mass storage device including: a third partition provided for booting the second physical node; and a fourth partition as part of the second resources. The first and the second physical nodes are further configured to provide third resources for a plurality of storage management processes.

Abstract: A computer cluster includes: a first compartment, further including a plurality of first physical nodes configured to provide first resources for guest virtual instances, each of the plurality of first physical nodes further including a mass storage device, the mass storage device further including: a first partition provided for booting the first physical node; and a second partition as part of the first resources; and a second compartment, further including a plurality of second physical nodes configured to provide second resources for guest virtual instances, each of the plurality of second physical nodes further including a mass storage device, the mass storage device including: a third partition provided for booting the second physical node; and a fourth partition as part of the second resources. The first and the second physical nodes are further configured to provide third resources for a plurality of storage management processes.

Abstract: A computer cluster includes: a first compartment, further including a plurality of first physical nodes configured to provide first resources for a first infrastructural virtual instance and second resources for guest virtual instances; and a second compartment, further including a plurality of second physical nodes configured to provide third resources for a second infrastructural virtual instance and fourth resources for guest virtual instances. Each of the plurality of physical nodes further includes a mass storage device, the mass storage device further including: a partition provided for booting the physical node; a partition as part of resources assigned to an infrastructural virtual instance; and a partition as part of other resources. The first infrastructural virtual instance and the second infrastructural virtual instance are configured for monitoring each other.

Abstract: The present invention relates to a process for the preparation of methacrylic acid or methacrylic esters, comprising the process steps of IA) preparation of 3-hydroxyisobutyric acid by a process comprising the process step of bringing a cell which has been genetically modified in comparison with its wild type in such a way that it is capable of forming more 3-hydroxyisobutyric acid, or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid in comparison with its wild type, into contact with a nutrient medium comprising, as carbon source, carbohydrates, glycerol, carbon dioxide, methanol, L-valine or L-glutamate under conditions under which 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid are formed from the carbon source, if appropriate, isolation of the 3-hydroxyisobutyric acid from the nutrient medium and also, if appropriate, neutralization of the 3-hydroxyisobutyric acid, IB) dehydration of the 3-hydroxyisobutyric acid with formation of methacrylic acid and also, where

Abstract: The present invention relates to an isolated DNA, which is selected from the following sequences: a) a sequence according to SEQ ID No. 01, b) an intron-free sequence that is derived from a sequence according to a) and encodes the same protein or peptide as the sequence according to SEQ ID No. 01, c) a sequence that encodes a protein or peptide, which comprises the amino acid sequence according to SEQ ID No. 02, d) a sequence that is at least 80% identical to a sequence according to a) to c), e) a sequence that hybridizes with the antisense strand of a sequence according to one of the groups a) to d) or would hybridize taking into account degeneration of the genetic code, f) a derivative of a sequence according to one of the groups a) to e) obtained by substitution, addition, inversion and/or deletion of one or more bases, g) a sequence that corresponds to SEQ ID No. 01 within the degeneration of the genetic code, h) a sequence with neutral sense mutations of SEQ ID No.

Abstract: The present invention relates to a cell which has been modified in comparison with its wild type in such a way that it is capable of forming more, by comparison with its wild, 3-hydroxyisobutyric acid or poly-hydroxyalkanoates based on 3-hydroxyisobutyric acid via methylmalonate-semialdehyde or 3-hydroxybutyryl-coenzyme A as precursors. The invention also relates to a method of generating a genetically modified cell, to the genetically modified cell obtainable by these methods, to a method of producing 3-hydroxyisobutyric acid or polyhydroxyalkanoates based on 3-hydroxyisobutyric acid, to a method of producing methacrylic acid or methacrylic esters, and to a method of producing polymethacrylic acid or polymethacrylic esters. The present invention furthermore relates to an isolated DNA, to a vector, to the use of this vector for transforming a cell, to a transformed cell, and to a polypeptide.

Abstract: This invention pertains to genes coding for phenol-induced proteins Five phenol-induced proteins isolated from Thauera aromatica. Three dominant phenol-induced proteins called F1, F2, and F3 respecitively were purified and sequenced to obtain the enzyme(s) that catalyze the 14CO2:4-hydroxybenzoate isotope exchange reaction and the carboxylation of phenylphosphate. The N-terminal amino acid sequences of these proteins as well as the N-terminus of the phenol-induced proteins (F4 and F5) were also determined.

Abstract: This invention pertains to genes coding for phenol-induced proteins-Five phenol-induced proteins isolated from Thauera aromatica. Three dominant phenol-induced proteins called F1, F2, and F3 respectively were purified and sequenced to obtain the enzyme(s) that catalyze the 14CO2:4-hydroxybenzoate isotope exchange reaction and the carboxylation of phenylphosphate. The N-terminal amino acid sequences of these proteins as well as the N-terminus of the phenol-induced proteins (F4 and F5) were also determined.

Abstract: A seal for a container, in particular, a refrigerated container having a door or two wings of the door, and having a door jamb having a corner zone comprising:(a) a strand shaped outer sealing profile made of elastomeric material;(b) the door having an outer side, the door having an inner side; and the door having a face side; and the outer profile being fastened on the face side of the container door or wing of the door;(c) the outer profile having two bow-shaped sealing lips, one of which is an outer lip for sealing the gap between the container door and the door jamb, and, respectively, the gap between the two wings of the door, with the outer lip embracing the corner zone of the door jamb and wing of the door, respectively;(d) a strand-shaped inner sealing profile serving as an inner seal being an elastomer arranged on the face side of the container door or wing of the door;(e) a first C-shaped rail for anchoring the inner sealing profile and a second C-shaped rail for anchoring the outer sealing profile,

Abstract: An apparatus for manufacturing an otoplastic. An otoplastic is manufactured directly in the ear of a hearing-impaired person in that a deformable envelope is pulled over a die or over a shell or over an overlayed over-shell. This apparatus is then supplied with flowing otoplastic material between the die and the envelope, being supplied therewith in the ear. The envelope expands and assumes the shape of the auditory canal. After hardening or curing of the otoplastic material in the ear of the hearing-impaired person, the envelope and the die are removed and a module of either an in-the-ear or of a behind-the-ear hearing aid is integrated therewith.

Abstract: A method and apparatus for manufacturing an otoplastic. An otoplastic is manufactured directly in the ear of a hearing-impaired person in that a deformable envelope is pulled over a die or over a shell or over an overlayed over-shell. This apparatus is then supplied with flowing otoplastic material between the die and the envelope, being supplied therewith in the ear. The envelope expands and assumes the shape of the auditory canal. After hardening or curing of the otoplastic material in the ear of the hearing-impaired person, the envelope and the die are removed and a module of either an in-the-ear or of a behind-the-ear hearing aid is integrated therewith.

Abstract: The invention relates to a mold for producing a T-shaped hose composed of a main hose having a sidewall with an opening and a secondary hose joined at one end to the sidewall opening of the main hose to form a "T". The mold includes a main mandrel for the main hose having a disk-shaped recess on which the main hose is mountable with its opening in registry with the mandrel recess and a secondary mandrel for the secondary hose having a cylindrical recess adjacent to one end thereof. The secondary mandrel is disengageably secured at the one end thereof to the main mandrel adjacent to the recess thereof, so that the mandrels are arranged in the form of a "T" and cooperate with one another to define an interior mold cavity at the zone of connection. The mold further includes an outer mold part that is mountable on the main hose and the secondary hose after each has been mounted on its respective mandrel parts.